Clinical Trials for Interferon alpha-2b

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticECOGMELE1609
09/08/2011
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.